Blog · Real-time PCR ·

Multiplex real-time PCR panels vs single-target tests: syndromic testing in the veterinary laboratory

A dog with a cough or a cat with diarrhoea rarely has exactly one pathogen, and the pathogen the clinician guesses is frequently not the one doing the damage. Syndromic panels exist because of that. This post explains how multiplex real-time PCR fits several targets into one tube, what it costs in analytical performance, and how a laboratory chooses between a panel and a single-target kit.

Real-time PCR analysers in a veterinary laboratory. Each fluorescence channel carries one target; a four-channel instrum
Real-time PCR analysers in a veterinary laboratory. Each fluorescence channel carries one target; a four-channel instrument runs a four-plex panel in one well.

Why syndromes, not pathogens

Canine infectious respiratory disease complex involves distemper virus, parainfluenza, adenovirus type 2, influenza, respiratory coronavirus, Bordetella bronchiseptica and Mycoplasma cynos, in any combination. Feline upper respiratory disease pairs calicivirus and herpesvirus with Mycoplasma, Chlamydia and Bordetella. Feline and canine diarrhoea spans parvovirus, coronavirus, Giardia, Tritrichomonas, Cryptosporidium, Clostridium and Salmonella. Surveys of clinical cases routinely find two or more agents in a third or more of positive samples.

A single-target test in this setting answers the question the clinician asked, not the question the patient poses. A negative parvovirus result in a vomiting puppy is reassuring only if the coronavirus, Giardia and Clostridium results are also known. A panel converts a sequence of guesses into one ordered answer.

How multiplexing works

Each target has its own primer pair and a probe labelled with a different fluorophore: FAM, HEX or VIC, ROX or Texas Red, Cy5, and on six-channel instruments Cy5.5 or a similar dye. The instrument reads each channel separately every cycle, so one well reports one curve per target. An internal control, usually an endogenous host gene or a spiked synthetic sequence, occupies one channel and confirms that extraction worked and the reaction was not inhibited.

Four to six targets per well is the practical ceiling on most instruments; larger panels are built as two or three wells per sample, which is why an eight-item gastrointestinal panel is packaged as multiple tubes.

What multiplexing costs, and how it is controlled

Primer competition. Targets share polymerase, nucleotides and cycle time, so a high-load target can suppress the amplification of a low-load one in the same tube. Well-designed panels balance primer concentrations and confirm during validation that each target's limit of detection in the multiplex is within a cycle or so of its singleplex value.

Cross-talk. Fluorophores with overlapping spectra bleed into neighbouring channels; the instrument's calibration and the panel's dye choice control this, and validation includes single-positive samples in each channel to prove it.

Interpretation. A panel produces more positives, some of them commensals or bystanders. Mycoplasma and Bordetella in particular are found in healthy carriers, so the report should carry the Ct value, and the clinician should read a late Ct on a carrier organism differently from an early Ct on distemper virus.

Singleplex real-time PCRMultiplex panel (4–6 targets)
Targets per reaction14–6 (one channel each)
Cost per pathogen resultHighestLowest
Hands-on time per sampleRepeated per targetOnce
Analytical sensitivityReferenceWithin about 1 Ct of singleplex when validated
QuantitationBestGood, per channel
Risk of missed co-infectionHighLow
Validation burdenLowerHigher (cross-talk, competition, all combinations)
Best fitConfirmation, monitoring, rare targetsFirst-line syndromic diagnosis

When a single-target kit is still the right choice

Confirmation of a panel positive with an independent assay. Quantitative monitoring of one pathogen over time, such as viral load under treatment, where the cleanest curve comes from a dedicated reaction. Rare or exotic targets that no panel carries, including zoonotic agents such as Brucella, Leptospira or Leishmania where the clinical question is specific. Regulatory or export testing that names a method. And any laboratory whose instrument has only one or two channels.

Building a panel menu

A veterinary laboratory serving general practice usually settles on a respiratory panel and a gastrointestinal panel for each of dog and cat, a vector-borne panel (Ehrlichia, Anaplasma, Babesia, Dirofilaria, Leishmania) shaped by the local tick and sandfly map, and a set of singleplex kits for confirmation and for the zoonotic and reproductive questions. All of them run on the same extraction, the same instrument and the same reporting template, which is the practical argument for sourcing the whole menu from one catalogue rather than assembling it from five suppliers with five master mixes.

The extraction step nobody advertises

Every panel is only as good as the nucleic acid that goes into it. Faeces, swabs and EDTA blood need different lysis chemistries; automated magnetic-bead extraction gives consistent yield and removes the inhibitors that otherwise flatten a multiplex curve. A laboratory scaling from a handful of samples a day to dozens moves from a 4-sample extractor to 16, 32 or 96, and that decision is made at the same time as the panel menu.

Written by the Medicare Vet product team from manufacturer data, WOAH guidance and published validation. Not a substitute for veterinary or laboratory advice in your market.

Questions

Does a multiplex lose sensitivity?

A well-validated panel keeps each target within about one cycle of its singleplex limit of detection. Ask for the validation data; it should include the multiplex and singleplex detection limits side by side.

How many targets fit in one well?

Four to six, one per fluorescence channel, with one channel usually reserved for the internal control. Larger panels are split across two or three wells per sample.

Should a panel positive be confirmed?

For a treatment-changing or reportable result, yes, with an independent singleplex assay or a second sample. Late Ct values on carrier organisms such as Mycoplasma or Bordetella need clinical context.